Chargement en cours...
Applying the discovery of the Philadelphia chromosome
The identification of the Philadelphia chromosome in cells from individuals with chronic myelogenous leukemia (CML) led to the recognition that the BCR-ABL tyrosine kinase causes CML. This in turn led to the development of imatinib mesylate, a clinically successful inhibitor of the BCR-ABL kinase. I...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Clinical Investigation
2007
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1934568/ https://ncbi.nlm.nih.gov/pubmed/17671641 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI31988 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|